ClinVar Miner

Submissions for variant NM_022124.6(CDH23):c.719C>T (p.Pro240Leu) (rs121908354)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Division of Hearing and Balance Research,National Hospital Organization Tokyo Medical Center RCV000005211 SCV000611798 pathogenic Deafness, autosomal recessive 12 2017-07-01 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000005211 SCV000914464 pathogenic Deafness, autosomal recessive 12 2018-08-14 criteria provided, single submitter clinical testing Across a selection of the available literature, the CDH23 c.719C>T (p.Pro240Leu) missense variant has been identified in a homozygous state in nine affected individuals, in a compound heterozygous state in 20 affected individuals, and in a heterozygous state in 21 affected individuals. The phenotypic spectrum of these patients varied from mild to profound hearing loss, with age of onset ranging from infant to adult onset, with the majority presenting with bilateral hearing loss (Wagatsuma et al. 2007; Miyagawa et al. 2012; Miyagawa et al. 2013; Kim et al. 2015). One patient who was heterozygous for the p.Pro240Leu variant, was diagnosed with Usher syndrome. This individual also carried a homozygous missense variant in the MYO7A gene (Yoshimura et al. 2014). Of the 21 affected heterozygotes with hearing loss, 19 were reported in a study where the second allele may not have been ascertained due to limitations of a genotyping assay; five were from families with at least two affected generations but segregation of the variant was not demonstrated by the authors (Miyagawa et al. 2012). Variants in CDH23 have not been historically reported in association with dominant hearing loss, however a dominant presentation cannot be ruled out in these families. The p.Pro240Leu variant was reported in two of 676 controls in a heterozygous state and is reported at a frequency of 0.001276 in the East Asian population of the Exome Aggregation Consortium database. Based on the collective evidence, the p.Pro240Leu variant is classified as pathogenic for autosomal recessive nonsyndromic hearing loss. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.
Illumina Clinical Services Laboratory,Illumina RCV001106128 SCV001263162 uncertain significance Usher syndrome type 1D 2017-07-18 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
OMIM RCV000005211 SCV000025389 pathogenic Deafness, autosomal recessive 12 2007-10-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.